TP53 and acute kidney injury: We found that Lip-1 could alleviate I/R-induced AKI through upregulating early growth response 1 (EGR1)/TP53/SLC7A11, and Lip-1 could also reduce kidney inflammation via recruiting macrophages and decreasing the release of inflammatory cytokines.